Protegrins and their derivatives are a new class of peptide antibiotics bas
ed on mammalian antimicrobial peptides. Their pharmacological properties in
clude an unusually broad spectrum of antimicrobial activity against Gram-po
sitive and Gram-negative bacteria, fungi and some enveloped viruses. Precli
nical and clinical studies of the lead compound, IB-367, developed for topi
cal applications, show promise for the prevention of chemotherapy- and radi
ation-induced oral mucositis.